::: 큐라티스 :::

Core Technology

Adjuvant Platform Technology

Adjuvan?

· Adjuvant is a substance used in combination with an antigen to enhance the in vivo cellular and humoral immune response to a particular antigen.
· Alum, which was developed over 70 years ago, is the most widely used immune enhancer used in commercial vaccines.
· In recent years, many researches have been achieved on innate immunity, and an innate immunity enhancer is being used as an adjuvant.
·Thus, the adjuvant can be used as a vaccine for various diseases by replacing only specific antigens, and we are working on applying them to various fields.

History of Vaccines

Developing Next-generation Adjuvant

Cell Therapy Platform Technology

· Present in the lymphatic system and intercellular spaces of various tissues, dendritic cells (DCs) are antigen presenting cells (APCs) having strong antigen-presenting abilities.
· DCs may either stimulate or regulate immunity, depending on the differentiating environment.
· Treatment using DC platform can minimize side effects because they are able to control antigen-specific immunity differently from conventional drugs.
· In our company, we are in the process of applying a cell therapy agent to intractable diseases, based on the technology of modulating the function of DCs.